Ville St-Laurent, MA, United States of America

Daniel McKay


Average Co-Inventor Count = 10.6

ph-index = 1


Location History:

  • Chute a Blandeaux, CA (2012)
  • Ville St-Laurent, MA (US) (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Daniel McKay in Pharmaceutical Science

Introduction: Daniel McKay, based in Ville St-Laurent, MA, has made notable strides in the field of pharmaceutical innovation, garnering a total of two patents. His work has significant implications in the treatment and management of viral and cardiovascular diseases, marking him as a pivotal figure in the biotechnology sector.

Latest Patents: One of McKay's latest patents focuses on HIV protease inhibitors. This invention involves 2,5,6-substituted morpholine derivatives aimed at inhibiting HIV protease and replication. The potential applications include the prophylaxis and treatment of HIV infections, as well as the management of AIDS. The compounds and their salts can be incorporated into pharmaceutical compositions, often in conjunction with other antivirals or immunomodulators.

The second patent showcases his work on renin inhibitors. This invention pertains to biphenyl-based renin inhibitor compounds featuring amino-terminal groups. These compounds are designed for treating cardiovascular events and addressing renal insufficiency, highlighting his commitment to tackling urgent health challenges.

Career Highlights: Daniel McKay's career includes significant tenures at prominent pharmaceutical companies, notably Merck Sharp & Dohme Corporation and Merck Canada Inc. His experiences at these leading firms have undoubtedly shaped his innovative research approach and product development strategies.

Collaborations: Throughout his career, McKay has collaborated with esteemed colleagues, including John A. McCauley and Christian Beaulieu. These partnerships have helped propel his initiatives and broaden the impact of his inventions within the pharmaceutical community.

Conclusion: Daniel McKay exemplifies the spirit of innovation within the pharmaceutical landscape. With a focus on impacting global health through his patents on HIV and renal therapies, his contributions are invaluable. As he continues to push the boundaries of scientific discovery, McKay remains a vital player in advancing medical treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…